DESMOPLASTIC SMALL ROUND CELL TUMOR
Clinical trials for DESMOPLASTIC SMALL ROUND CELL TUMOR explained in plain language.
Never miss a new study
Get alerted when new DESMOPLASTIC SMALL ROUND CELL TUMOR trials appear
Sign up with your email to follow new studies for DESMOPLASTIC SMALL ROUND CELL TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on childhood cancers in new trial
Disease control Recruiting nowThis early-stage trial tests a treatment where a child's own immune cells are collected, modified to better attack cancer, and given back as a one-time infusion. It is for children and young adults up to age 21 with solid tumors that have come back or not responded to standard th…
Matched conditions: DESMOPLASTIC SMALL ROUND CELL TUMOR
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated May 16, 2026 23:48 UTC
-
New stem cell combo aims to fight stubborn childhood cancers
Disease control Recruiting nowThis study tests a stem cell transplant that removes certain immune cells (alpha/beta T cells and CD19+ B cells) and adds a drug called zoledronic acid. The goal is to help the donor cells attack the tumor without causing severe side effects. It is for children and young adults a…
Matched conditions: DESMOPLASTIC SMALL ROUND CELL TUMOR
Phase: PHASE1, PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated May 16, 2026 23:38 UTC
-
New drug duo targets rare abdominal cancer in phase 2 trial
Disease control Recruiting nowThis study tests a combination of two chemotherapy drugs, lurbinectedin and irinotecan, in 20 people with advanced desmoplastic small round cell tumor (DSRCT) that cannot be removed by surgery. The goal is to shrink or control the tumor and track side effects. An optional part of…
Matched conditions: DESMOPLASTIC SMALL ROUND CELL TUMOR
Phase: PHASE2 • Sponsor: Italian Sarcoma Group • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New hope for rare sarcomas: immune drug plus chemo tested
Disease control Recruiting nowThis study tests whether adding the immunotherapy drug tislelizumab to standard chemotherapy can help shrink or control advanced soft tissue sarcomas that cannot be removed by surgery. About 45 adults aged 18-75 with certain sarcoma types will receive the combination as their fir…
Matched conditions: DESMOPLASTIC SMALL ROUND CELL TUMOR
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New hope for young sarcoma patients: experimental drug combo enters trials
Disease control Recruiting nowThis study tests a new drug called PEEL-224 combined with two standard chemotherapy drugs (vincristine and temozolomide) in adolescents and young adults whose sarcomas have come back or not responded to treatment. The goal is to find the safest dose and see if the combination shr…
Matched conditions: DESMOPLASTIC SMALL ROUND CELL TUMOR
Phase: PHASE1, PHASE2 • Sponsor: David S Shulman, MD • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
New hope for rare childhood cancers: drug trial targets stubborn sarcomas
Disease control Recruiting nowThis study is testing a drug called lurbinectedin in people aged 10 and older whose solid tumors (like Ewing sarcoma) have come back or not responded to standard treatment. The goal is to see if the drug is safe and can shrink tumors or delay their growth. Participants must have …
Matched conditions: DESMOPLASTIC SMALL ROUND CELL TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
Scientists dive deep into rare sarcomas to unlock immune secrets
Knowledge-focused Recruiting nowThis study aims to learn more about the immune system's role in rare soft tissue sarcomas. Researchers will collect and analyze blood and tumor samples from 400 patients with these uncommon cancers. The goal is to find patterns that could help predict how the disease will progres…
Matched conditions: DESMOPLASTIC SMALL ROUND CELL TUMOR
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated May 11, 2026 20:38 UTC
-
New patient registry aims to unlock secrets of rare cancer
Knowledge-focused Recruiting nowThis study creates a database of health information from 250 people diagnosed with desmoplastic small round cell tumor (DSRCT), a rare cancer. Participants of any age can join by sharing their medical history and ongoing health data. Researchers will use this information to learn…
Matched conditions: DESMOPLASTIC SMALL ROUND CELL TUMOR
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated May 01, 2026 16:00 UTC